JAK-STAT signaling pathway in the pathogenesis of atopic dermatitis: An updated review.

Front Immunol · 2022 · PMC9773077 · PMID 36569854

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Compared with dupilumab, the 200 mg dose of abrocitinib showed a better IGA 0/1 or EASI75 response during the 16-week treatment period but did not reach statistical significance ( 117 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.